Investing.com - ATAI Life Sciences BV reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
ATAI Life Sciences BV announced earnings per share of $-0.22 on revenue of $24M. Analysts polled by Investing.com anticipated EPS of $-0.24 on revenue of $0.
ATAI Life Sciences BV shares are down 23.1% from the beginning of the year, still down 83.11% from its 52 week high of $16.10 set on November 10, 2021.
ATAI Life Sciences BV follows other major Healthcare sector earnings this month
ATAI Life Sciences BV's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar